Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Clinical trial NCT00027638 · COMPLETED

Trial details

NCT number: NCT00027638
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Cancer Neoplastic Syndrome

Start date: 2001-03-01
Primary completion: 2003-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.